Study | Reason for exclusion |
---|---|
Angsten 2002 | Included term infants. Population included 36‐ to 41‐week newborn infants ≤ 4 days of age needing surgery and expected to require total PN for ≥ 5 days. |
Ariyawangso 2014 | Included newborn infants requiring surgery and term infants. Infants were randomised to receive SMOFlipid 20% (experimental group, n = 21) or Intralipid 20% (control group, n = 21). |
Lima 1988 | Included term infants up to 38 weeks' gestation. |
Magnusson 1997 | Included newborn infants requiring surgery and term infants. |
Webb 2008 | Included term infants with mean gestation of infants 37.0 (SD 3.6) weeks and 36.7 (SD 3.0) weeks in the 2 arms of the study. |
Wilson 1997 | Compare "aggressive parenteral nutrition" in preterm infants vs "conventional parenteral nutrition." The "aggressive nutrition group" received a higher rate of lipids, proteins, dextrose and 33% of participants in this group received insulin besides getting medium chain and long chain triglyceride‐based LE (Lipofundin). The conventional nutrition group received a lesser percentage of dextrose, lesser rate of lipids (S‐LE) and no insulin. The duration of LE was a median of 20 days (interquartile range 12 to 28 days) in the aggressive nutrition (MS‐LE) group vs a median of 6 days (interquartile range 2–15 days) in the conventional nutrition (S‐LE group). This study, done in 1997, reported advantages of the aggressive PN regimen vs conventional PN. |
MS‐LE: medium‐chain triglyceride‐soybean oil lipid emulsion; n: number of participants; PN: parenteral nutrition; S‐LE: soybean oil‐based lipid emulsions; SD: standard deviation.